Observing HIV infection risks among high-risk individuals in Vienna
Characterization of Patients at High Risk for the Acquisition of Sexually Transmitted Infection With the Human Immunodeficiency Virus (HIV) - a Clinical Study
Medical University of Vienna · NCT05326061
This study looks at the risk factors for new HIV infections among HIV-negative men who have sex with men and transgender individuals in Vienna to better understand how the virus spreads in these groups.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Medical University of Vienna (other) |
| Locations | 1 site (Vienna) |
| Trial ID | NCT05326061 on ClinicalTrials.gov |
What this trial studies
This observational cohort study aims to investigate the epidemiology and risk factors associated with new HIV infections among individuals at high risk, specifically HIV-negative men who have sex with men (MSM) and transgender individuals. Participants will be assessed for high-risk behaviors, including inconsistent condom use, recent sexually transmitted infections (STIs), and engagement in chemsex. Clinical data will be collected through laboratory tests and questionnaires to understand the incidence of HIV and related conditions. The study will provide valuable insights into the transmission dynamics of HIV in this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates for this study are HIV-negative MSM and transgender individuals over 18 years old who engage in high-risk sexual practices.
Not a fit: Patients who consistently use condoms and do not engage in high-risk behaviors may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prevention strategies and targeted interventions for individuals at high risk of HIV infection.
How similar studies have performed: Other studies have shown success in understanding HIV transmission dynamics among high-risk populations, making this approach both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. High risk for acquiring HIV defined as followed: HIV-negative MSM and transgender individuals who (i) do not use condoms consistently with casual partners and/or with HIV-positive partners who are not on treatment and/or (ii) recently acquired an STI and/or (iii) recently used PEP and/or (iv) frequently engage in 'chemsex'. 2. Age \>18 years and \<100 years. 3. Written informed consent for this registry study. Exclusion Criteria: 1\. Withdrawal of the written informed consent.
Where this trial is running
Vienna
- Medical University of Vienna — Vienna, Austria (RECRUITING)
Study contacts
- Study coordinator: David Chromy, MD
- Email: david.chromy@meduniwien.ac.at
- Phone: +43 1 40400 77360
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: HIV Infections, HIV Pre-Exposure Prophylaxis, Sexually Transmitted Diseases, Gonorrhea, Chlamydia, Syphilis